mdm2 Gene and Multidrug Resistance in Glioblastoma Cells
Author Information
Author(s): S Kondol, Y Kondo, H Hara, R Kaakaji, JW Peterson, T Morimura, J Takeuchi, GH Barnett
Primary Institution: The Cleveland Clinic Foundation
Hypothesis
Does the mdm2 gene induce the expression of the mdrl gene and P-glycoprotein in human glioblastoma cells?
Conclusion
The mdm2 gene induces the expression of the mdrl gene and P-glycoprotein, leading to resistance against chemotherapy in glioblastoma cells.
Supporting Evidence
- The mdm2 gene was shown to induce the expression of the mdrl gene and P-glycoprotein in U87-MG cells.
- MDM2-U87-MG cells exhibited significant resistance to the chemotherapy drugs VP-16 and doxorubicin.
- Transfection with mdm2 resulted in the overexpression of MDM2 protein and P-glycoprotein.
Takeaway
The mdm2 gene helps cancer cells resist treatment by making them produce a protein that pumps out the medicine, making it less effective.
Methodology
Human glioblastoma U87-MG cells were transfected with the mdm2 gene, and the effects on mdrl and P-glycoprotein expression were assessed using various assays.
Limitations
The study does not assess the stability of increased mdm2 and P-gp expression in transfectant sublines.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website